Intellia Therapeutics Inc buy Canaccord Genuity Group Inc.
Start price
28.04.26
/
50%
€11.66
Target price
28.04.27
€49.51
Performance (%)
0.34%
Price
08:48
€11.70
Summary
This prediction is currently active. The BUY prediction by Canaccord_Genuity_Gr for Intellia Therapeutics Inc is nearly unchanged. This prediction currently runs until 28.04.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Intellia Therapeutics Inc | 0.34% |
| iShares Core DAX® | -0.372% |
| iShares Nasdaq 100 | 2.269% |
| iShares Nikkei 225® | 1.433% |
| iShares S&P 500 | 1.216% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NTLA) had its price target raised by Canaccord Genuity Group Inc. from $48.00 to $58.00. They now have a "buy" rating on the stock.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by Canaccord_Genuity_Gr for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€11.99
03.03.26
03.03.26
€41.04
03.03.27
03.03.27
-2.38%
08:48
08:48
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€33.50
13.04.23
13.04.23
€59.72
13.04.24
13.04.24
-29.85%
14.04.24
14.04.24